Stephen Uden - 15 Feb 2024 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Chief Executive Officer, Director
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
15 Feb 2024
Transactions value $
$0
Form type
4
Filing time
16 Feb 2024, 18:22:25 UTC
Previous filing
06 Feb 2023
Next filing
19 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +216,000 $0 216,000 15 Feb 2024 Common Stock 216,000 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 15, 2028.